Icon

INPEFA (NDA216203)- (200MG,400MG)

SOTAGLIFLOZIN LEXICON PHARMS INC
200MG,400MG
No No
2030-Oct-07 2028-May-26
None None
None No
INPEFA is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with: • heart failure or • type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors.
0 0 0
Total Other Developers None
Drugs with Suitability No
200MG ** ** - - -
400MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.